Abstract 37 GATA5 is a member of the GATA zinc finger transcription factor family involved in tissue-specific tran-38 scriptional regulation during cell differentiation and embryogenesis. Previous reports indicate that null 39 mutation of the zebrafish GATA5 gene results in embryonic lethality, while deletion of exon 1 from the 40 mouse GATA5 gene causes only derangement of female urogenital development. Here, we have identi-41 fied an alternate promoter within intron 1 of the mouse GATA5 gene that transcribes a 2.5 kb mRNA that 42 lacks exon 1 entirely, but includes 82 bp from intron 1 and all of exons 2-6. The alternative promoter was 43 active during transient transfection in cultured airway myocytes and bronchial epithelial cells, and drove 44 reporter gene expression in gastric epithelial cells in transgenic mice. The 2.5 kb alternative transcript en-45 codes an N-terminally truncated "short GATA5" comprising aa 226-404 with a single zinc finger, that 46 retains ability to transactivate the ANF promoter (albeit less efficiently than full-length GATA5). Another 47 new GATA5 transcript contains all of exons 1-5 and the 5' portion of exon 6, but lacks the terminal 1143 48 bp of the 3' UTR from exon 6. These findings extend current understanding of the tissue distribution of 49 GATA5 expression and suggests that GATA5 expression and function are more complex than previously 50 appreciated. 51 52
Introduction 54
The GATA transcription factors contain a highly conserved DNA binding domain consisting of two zinc 55 fingers that mediate binding to the sequence (A/T)GATA(A/G). These factors have been divided into two 56 subfamilies, GATA1, 2, and 3, and GATA4, 5, and 6 based on their expression patterns and amino acid 57 sequence homologies. GATA1, 2, and 3 genes are prominently expressed in hematopoietic cells and ecto-58 derm derivatives while GATA4, 5, and 6 genes are expressed in various mesoderm and endoderm-derived 59 tissues (19, 26) . 60 61 GATA5 temporal and spatial expression patterns suggest its involvement in tissue-specific transcriptional 62 regulation during cell differentiation and embryogenesis. In zebrafish, GATA5 expression is detected by 63 4.3 hpf in the yolk syncytial layer and at 9 hpf in endoderm and mesoderm. A critical role of GATA5 in 64 heart development was demonstrated by the discovery that null mutation of the GATA5 gene (faust) in 65 zebrafish results in embryonic lethality due to defects in endocardial and myocardial differentiation mi-66 gration (10, 28) . Xenopus GATA5 is expressed in the yolk-rich vegetal cells of embryos from the early 67 gastrula stage onwards and in the sub-blastoporal endoderm during mid-gastrula stages, revealing an im-68 portant role for GATA5 in endoderm differentiation (32). In chick, GATA5 is transcribed at its highest 69 levels in a zone of epithelial cells apical of the progenitor crypt cells, suggesting a function of GATA5 in 70 regulation of terminal differentiation (7). During mouse development, GATA5 is expressed initially in the 71 Page 4 non-mutually exclusive possibilities: 1) unlike GATA4 or GATA6 deletion, GATA5 gene deletion does 79 not result in embryonic lethality in mice, and/or 2) there is an alternative GATA5 transcript that excludes 80 exon 1, but which nonetheless encodes a functional GATA5 variant that fulfills some of the roles of full-81 length GATA5. 82 Page 7 cDNA was PCR-amplified using primers that map to exon 1 (5'-AGCCTTCGACAGCA-GCATC-3') and 154 exon 5 (listed above), and sequence corresponding to 303 bp of the short GATA5 cDNA was amplified 155 using the intron 1 and exon 3 primers listed above. A 159 bp fragment of the b-actin cDNA was also am-156 plified using forward primer 5'-TTGCTGACAGGATGCAGAAGGAGA-3' and reverse primer 5'-157 ACTCCTGCTTGCTGATCCACATCT-3'. The PCR protocol was as listed above, except that 35 ampli-158 fication cycles were used. 159
160
Alternative GATA5 promoter-luciferase reporter plasmids. The pGL3-basic vector (Promega, Madison, 161 WI) was used to create promoter-reporter plasmids to measure potential alternative GATA5 promoter ac-162 tivities. A series of DNA fragments comprising bp +890, +1348, or +1895 to +2312 of the mouse GA-163 TA5 gene (numbering is relative to the previously known GATA5 transcription start site) were generated 164 by PCR amplification and inserted into MluI/NheI sites upstream of the firefly luciferase gene. Sense 165 primers were: 5'-CACACGCGTAACTAAGGCGCGCAGCAATAAACC-3' (corresponding to bp +890 166 to +913); 5'-CACACGCGTACCACAGCCATCTTGTTCTGCAAC-3' (corresponding to bp +1348 to 167 +1371); 5'-CACACGCGTCCATCCATTTCCTTCTGCCTGCTTC-3' (corresponding to bp +1895 to 168 +1919). The antisense primer was 5'-CACACTAGTATTGCATAGATAGTGTCCGGTGCC-3' (corres-169 ponding to bp +2289 to +2312); MluI or SpeI sites included in these primers are underlined. PCR amplifi-170 cations were performed with Taraka LA Taq TM polymerase and GC buffer recommended by the supplier 171 (Takara, Madison, WI). All constructs were verified by DNA sequence analysis and purified by Free Plasmid Maxi Kit (Qiagen, Valencia, CA). 173
174
Expression plasmids. Total RNA was extracted by the ToTALLY RNA™ Kit (Ambion) from lungs of 8Page 8 region upstream of the start codon in exon 1 (5'-CACGAATTCTCTGCAGGTCAAGCTCG-3') and an 179 antisense primer corresponding to the region spanning the stop codon on exon 6 (5'-CACCTCGAGT-180 GTGGTGACAGTTTCCTGAGC-3'); EcoRI and XhoI sites are underlined. For expression vector 181 pcDNA-GATA5-s encoding short GATA5, a portion of the GATA5 cDNA encoding amino acid residues 182 226 to 404 was amplified with a sense primer corresponding to the region including the predicted new 183 start codon (underlined) in exon 2 (5'-CACGAATTCTGCGGCCTCTATCACAAGATGAACGGGGT-184 CAACCG-3') and the above antisense primer within exon 6. The resultant PCR fragments were digested 185 with EcoRI and Xhol and cloned into the EcoRI-Xhol sites of pcDNA3.1 (Invitrogen), which directs 186 cDNA expression under control of the CMV promoter. Both expression plasmids were sequenced and pu-187 rified with an EndoFree Plasmid Maxi Kit (Qiagen). The expression vector pcDNA-GATA4 and the atrial 188 naturietic factor (ANF)-promoter/luciferase reporter plasmid were described previously (22, 29) . 189
190
Cell culture. Canine tracheal smooth muscle (CTSM) cell cultures were established as described pre-191 viously (9) and cells from the second passage were used for transfection assays. 16HBE14o- (generously 192 provided by Dr. D.C. Gruenert) and NIH3T3 cells (ATCC, Manassas, VA) were maintained in co's Modified Essential Medium (DMEM)/F12 supplemented with 10% fetal bovine serum, 100 units/ml 194 penicillin, and 100 μg/ml streptomycin at 37°C in a 5% CO 2 humidified incubator. 195 plates at 60,000 cells/well of CTSM cells or 16HBE14o-cells with 1 µg pGL3-basic or equal molar 198 amounts of pGL3-basic-derived plasmids containing mouse GATA5 promoter constructs, and 3 ng of 199 pKT-null vector containing the Renilla luciferase reporter gene as an internal control. In experiments with 200 forced expression of GATA5 transcription factors, 1 µg of expression vectors pcDNA-GATA4, pcDNA-201 GATA5-f, or pcDNA-GATA5-s, or empty pcDNA3.1 (as control) were co-transfected along with 1 µg of 202 LacZ gene contained therein. The GATA5 genomic sequence from +890 bp to +2312 bp was amplified by 223 PCR using the primers listed above, digested with NheI, and ligated into SmaI-NheI digested pMB105. 224
The pIRES2-EGFP vector (Clontech, Mountain View, CA) was used as template to amplify its IRES-225 EGFP sequence with sense primer 5'-CACAGATCTATCCGC-CCCTCTCCCTCC-3' and antisense pri-226 mer 5'-CACCTGCAGAACAACACTCAACCCTATCT-CG-3' (restriction sites underlined). A point mu-227 tation was introduced by PCR to delete a NotI site in the IRES-EGFP sequence. BglII-and PstI-digestedPage 10 IRES-EGFP was isolated and inserted into the BglII-PstI site of pMB105 downstream of the LacZ gene. 229
The alternative GATA5 promoter reporter construct built in pMB105 thus contained a 6.2-kb transgene 230 cassette, including 1.4 kb potential alternative GATA5 promoter, 3.1 kb LacZ gene and 1.7 kb IRES and 231 EGFP with SV40 early mRNA polyadenylation signal. The construct was verified by sequencing and the 232 linear transgene released by digestion with NotI ( Figure 4A ). Transgenic mice harboring this cassette 233 were generated by the transgenic mouse core facility of the University of Chicago Animal Resources Cen-234 ter. 235 236 X-gal staining. Tissues dissected from alternative GATA5 promoter adult transgenic mice and wild-type 237 C57BL/6J mice were rinsed with phosphate buffer solution then fixed for 1 hr with 2% paraformaldehyde 238 on ice. After three washes with phosphate buffer solution, the tissues were treated at 37°C overnight with 239 1 mg/mL X-gal, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 0.01% NP-40 and 0.1% 240 deoxycholate. Tissues were embedded in paraffin, sectioned, and counterstained with eosin (Sigma). 241
242
Cell and tissue immunostaining. NIH 3T3 cells transiently transfected with either pcDNA-GATA5-f or 243 pcDNA-GATA5-s, were fixed with 1% paraformaldehyde for 10 min, washed five times with PBS, per-244 meabilized with 0.1% Triton X-100 in PBS for 5 min, preincubated with 10% goat serum-PBS for 15 min 245 and incubated with polyclonal antibodies against GATA5 (diluted 1/500, Sigma) and Alexa 488-246 phalloidin (diluted 1/100, Invitrogen-Molecular Probes) in 1% BSA-PBS for two hrs at room temperature 247 in a humidified chamber. After three washes of 5 min each in PBS, GATA5 was detected with an Alexa 248 594-conjugated goat anti-mouse antibody (1/250 dilution; Invitrogen-Molecular Probes), and counters-249 tained with DAPI. Fluorescence micrographs were taken on an Axlesia 200 microscope and images pseu-250 docolored and merged using ImageJ (NIH, Bethesda, MD). Tissues from GATA5 promoter/reporter 251 transgenic mice were frozen in OCT, and 6 μ frozen sections were immunostained for EGFP using anti-252 Page 11 anti-rabbit secondary antibody, and 3,3'-diaminobenzidine after permeabilization by 5 min incubation in 254 0.5% NP40 and quenching endogenous peroxidase activity by 5 min incubation with Peroxidase Block 255 (Dako, Glostrup, Denmark) . 256 257
Results

258
Identification of two alternative GATA5 transcripts. Northern analysis performed using poly-A+ RNA 259 from a variety of mouse tissues and probes corresponding to GATA5 5'UTR in exon 1, GATA5 exons 2-260 6, and GATA5 far 3'UTR in exon 6 revealed three transcripts approximately 3.3 kb, 2.5 kb, and 2.1 kb in 261 size ( Figure 1A ). Two bands (3.3 kb and 2.1 kb) were detected with the GATA5 5' UTR probe and GA-262 TA5 exon 2-6 probe prominently in intestine, stomach, lung, and kidney. However, the 2.1 kb band was 263 not present when the GATA5 3'UTR probe was used. In addition, a much weaker hybridizing band of 2.5 264 kb was evident in intestine. We found similar results upon northern analysis of total RNA from small in-265 testinal mucosa ( Figure 1B ). The previously known 3.3kb transcript was identified with all three probes, 266 confirming that it includes sequences within exons 1, 2-6, and the far 3'end of exon 6. In contrast, the 2.1 267 kb transcript hybridized with GATA5 5'UTR and GATA5 exons 2-6 probes, but not the 3'UTR probe, 268
indicating that it lacks the 3' terminal sequence of the full-length GATA5 mRNA (3.3 kb). The third, 269 much less abundant 2.5 kb transcript hybridized with exons 2-6 and 3' UTR probes, but not the 5'UTR 270 probe, indicating that it omits this sequence from exon 1. 271
272
Identification of transcription start site and 3' end in the alternative GATA5 mRNAs. We employed 5' 273 RLM-RACE to amplify mouse stomach cDNAs only from full-length capped mRNAs and so to map the 274 transcription start sites of mouse GATA5 mRNA. Besides recovering the previously known GATA5 tran-275 scription start site in exon 1, we discovered a novel transcription start site in intron 1, at bp +2121 of the 276 mouse GATA5 gene, located 82 bp upstream of exon 2. Sequence analysis disclosed that the first exon of 277 this novel GATA5 transcript includes 258 bp, comprising 82 bp of intronic sequence immediately up Page 12 stream of exon 2 and the whole 176 bp exon 2; sequence corresponding to exon 3 was also present in the 279 PCR product, confirming that this transcript splices normally to exon 3. 5' RLM-RACE was repeated and 280 a similar product recovered using total RNA from mouse lung and heart. 281
282
To identify whether this new GATA5 transcript shares the same downstream exons and 3'UTR as the 283 full-length (3.3 kb) GATA5 mRNA, GATA5 cDNA was reverse transcribed with a 22 nucleotide gene 284 specific primer corresponding to the 3' end of the full-length GATA5 transcript using total RNA from 285 mouse lung or stomach. PCR amplification of GATA5 cDNA was the performed with a sense primer cor-286 responding to the first (most 5') 24 nucleotides of the putative novel transcript (in intron 1) and an anti-287 sense primer that maps to the 3'UTR. We found that the amplified sequence consists of 82 bp upstream of 288 exon 2 at its 5' end and is thereafter identical to exons 2 to 6 of full-length GATA5 transcript. These data 289 unequivocally confirm that a novel transcription start site occurs at bp +2121 of the mouse GATA5 gene, 290 and indicate that this new GATA5 mRNA of 2483 bp is expressed in mouse stomach, lung and heart. This 291 sequence is consistent with the 2.5 kb GATA5 transcript observed in intestine. 292
293
The sequences of the 3′ RACE products revealed two different termini of GATA5 cDNAs. One was iden-294 tical with the previously known 3' end of full-length GATA5 transcripts, but a novel 3′ terminus of GA-295 TA5 mRNA was also found, corresponding to bp 2106 of the previously known full-length GATA5 tran-296 script (bp +8398 of the mouse GATA5 gene); transcripts with this novel 3' end lack the terminal 1143 bp 297 of the 3' UTR. The predicted resultant 2.1 kb GATA5 transcript is evidently abundantly expressed, as 298 shown in Figures 1A and 1B . Figure 1C shows the inferred exon usage of all three GATA5-encoding 299 mRNAs. Note that an ATG codon in exon 2 is in frame with the full-length GATA5 cDNA; this sug-300 gested the possibility that the 2.5 kb GATA5 transcript that lacks exon 1 might nonetheless encode an N-301 terminally truncated "short" GATA5, whose translation start site might occur at the indicated ATG in exPage 13 304 Short GATA5 is expressed in gut. To validate the expression and assess the tissue distribution of mRNA 305 encoding short GATA5, we performed RT-PCR using GATA5 intron 1 primer which is specific for short 306 GATA5 mRNA. Figure 1D shows that mRNAs encoding short GATA5 isoform is expressed in a similar 307 distribution to full-length GATA5 mRNA among tissues. Both full-length and short GATA5-encoding 308 mRNAs are most abundant in intestine, stomach, and lung, and are also expressed at low levels in heart 309 and kidney. In contrast, very little or no GATA5 mRNAs appear in liver, spleen, brain, or thymus. In ad-310 dition, western analysis demonstrates full-length GATA5 (~45 kD) in intestinal mucosa from four regions 311 indicated in Figure 1E and short GATA5 (~27 kD) is present in proximal colonic mucosa. The latter con-312 firms that short GATA5 is indeed expressed endogenously. 313
314
In the Affymetrix Mouse Genome 430 2.0 Array, two probe sets (1450125_at and 1450126_at) detect 315 GATA5 expression. Probe 1450125_at is derived from full-length GATA5 cDNA bp 2668-2985 while 316 probe 1450126_at corresponds to bp 1507-2085 Because it lacks bp 2107-3249 of the full-length GATA5 317 cDNA, the novel 2.1 kb transcript cannot be detected by the probe set 1450125_at. In contrast, the probe 318 set 1450126_at can detect all isoforms of GATA5 transcripts. This suggested to us that the apparent ab-319 undance of GATA5 as judged by hybridization to 1450126_at should exceed that suggested by hybridiza-320 tion to 1450125_at, assuming that the entire transcript is reverse-transcribed during processing of the 321 mRNA for microarray hybridization. To test this prediction, we analyzed three sets of lung gene expres-322 sion previously published by us (11, 17, 31) 
, Version 3 of the Genomics Institute of the Novartis Research 323
Foundation's Mouse GeneAtlas (13), and a report of colonocyte gene expression (16). In each of these 324 studies, the GATA5 signal intensities reported by probe set 1450126_at were higher than those reported 325 by probe set 1450125_at in at least 90% of samples (P<0.0001 for each data set) ( Table 1) . 326 Page 14 Genomic sequence within GATA5 intron 1 has transcription promoting activity. To determine whether an 328 alternative promoter transcribes the novel 2.5 kb GATA5 mRNA in mouse, we amplified a series of DNA 329 fragments and cloned these upstream of the luciferase cDNA in pGL3-basic (Figure 2A ). These constructs 330 comprised a 5' deletion series with 3' ends in exon 2 upstream of the alternate initiation codon at +2312 331 of GATA5 gene. Reporter plasmids were transiently transfected into CTSM cells and 16HBE14o-cells, 332
and promoter activity determined as firefly luciferase activity normalized to Renilla luciferase activity. 333
The genomic DNA sequence comprising +890 bp to +2312 bp had clearcut promoter activity in CSM 334 cells (7.4-fold that of empty pGL3-basic) and 16HBE14o-cells (5.8-fold that of empty pGL3-basic) 335 ( Figure 2B ). Furthermore, the genomic DNA sequence spanning +890 bp to +1347 bp evidently contains 336 positive cis-acting transcriptional regulatory elements, as their deletion reduced promoter activity. This 337 finding supports the possibility that an intron 1 promoter located at mouse genomic DNA sequence +890 338 to +2312 drives the transcription of the 2.5 kb GATA5 transcript in mouse. 339
340
Putative intron 1 promoter drives reporter gene expression in transgenic mice. To test whether the intron 341 1 GATA5 sequence exhibits promoter activity in vivo, we generated random-integration transgenic mice 342 on the C57Bl/6 background, using a transgene in which bp +890 to +2312 of the GATA5 gene drove ex-343 pression of a dual reporter cassette (lacZ-IRES-EGFP) ( Figure 3A) . A 6.2-kb transgene (5' -NotI -in-344 tronic GATA5 promoter -lacZ -IRES -EGFP -SV40 polyA signal -NotI -3') was purified and in-345 jected into ES cells for transgenic mouse generation in the University of Chicago transgenic core facility. 346 Transgenic mice were genotyped by Extract-N-Amp Tissue PCR Kits (Sigma, St. Louis, MO). X-gal 347 staining and immunostaining were used to detect β-galactosidase activity and EGFP expression, respec-348 tively. In each of two founder lines of transgenic mice studied, the intron 1 GATA5 promoter directed 349 both β-galactosidase and EGFP expression in gastric epithelial cells ( Figure 3B Moreover, immunofluorescent staining confirmed that both full-length ( Figure 4B ) and short ( Figure 4C ) 362 GATA5 were located in the nucleus when expressed by transient transfection in NIH 3T3 cells. To assess 363 whether short GATA5 retains transcription promoting activity, we co-transfected expression plasmids en-364 coding short GATA5, full-length GATA5, or GATA4 with a reporter plasmid in which firefly luciferase 365 expression is driven by the GATA-sensitive ANF promoter. As shown in Figure 5 , short GATA5 signifi-366 cantly transactivates the GATA-sensitive ANF promoter, though to a lesser extent than does full-length 367 GATA5 or GATA4. 368 369 Discussion 370
In this study, we identified an alternative promoter region of mouse GATA5 gene located at bp +890 to 371 +2312 that drives the transcription of a 2.5 kb GATA5 mRNA with a novel transcription start site at bp 372 +2121 within intron 1. It is a common feature for GATA family members to possess two promoters and 373 two initiation codons. In the mouse, a distal promoter of the GATA1 gene drives testis-specific expres-374 sion, while a more proximal promoter directs transcription in hematopoietic cells (24, 30) . Similarly, 375 mouse GATA2 expression is regulated by two distinct promoters. One, whose structure is homologous to 376 that of the Xenopus and human GATA2 gene promoters, directs mouse GATA2 transcription in all cells, Page 16 while the other promoter regulates the expression of GATA2 specifically in hematopoietic cells (4, 6, 18) . 378
Human and mouse GATA3 genes also are controlled by two promoters that may direct lineage-and tis-379 sue-specific expression. The human and mouse GATA6 genes possess two alternative promoters and two 380 initiation codons, though both transcripts are expressed in essentially the same tissue-specific and deve-381 lopmental stage-specific pattern (3). Two promoter regions regulate transcription of chicken GATA5 382 mRNAs that encode two distinct GATA5 proteins (15). It is not surprising therefore that there are distinct 383 promoters mediating the transcriptional regulation of GATA5 genes in mouse. The use of alternative 384 promoters and transcriptional start sites can create diversity and flexibility in the regulation of gene ex-385 pression (2). 386
387
Our finding of a second GATA5 promoter in intron 1 (Figures 2 and 3 ) that drives expression of a short 388 but still functional GATA5 variant, in a tissue distribution that parallels expression of mRNA encoding 389 full-length GATA5 ( Figure 1D ), makes plausible our speculation that previously reported GATA5 exon 390 1-deleted mice (20) might have retained a transcriptionally active short form of GATA5 protein. The pre-391 dicted 181 aa GATA5 protein would retain only one zinc finger and the C-terminal activation domain, 392 and would have had a structure quite similar to the alternative isoform of chicken GATA5, in which splic-393 ing from an upstream alternative exon 1 excludes the coding exon 1 and the consequent mRNA encodes a 394 partially functional single zinc finger isoform of chicken GATA5 (15). GATA5 exon 1-deleted mice are 395 not presently available to evaluate the expression and function of short GATA5 in the absence of full-396 length GATA5. However, our studies indicate that an immunoreactive short isoform can be synthesized in 397 vitro and localizes to the nucleus, similar to full-length GATA5 (Figure 4 ). Even with a single zinc finger, 398 short GATA5 still transactivates the GATA-sensitive ANF promoter though to a lesser extent than full-399 length GATA5 or GATA4 ( Figure 5 ). Furthermore, short GATA5 is expressed endogenously in proximal 400 colon ( Figure 1E ) along with full-length GATA5. The physiological role of endogenously expressed 401 short GATA5 has yet to be determined.
Using 3' RACE, we also identified the structure of a 2.1 kb GATA5 transcript that includes exons 1-5 and 404 the 5' half of exon 6, but lacks the 3' terminal 1143 bp of exon 6; this transcript is likely the same as the 405 apparently 1.8 kb transcript evident in previously published northern blots (5, 21). The tissue distribution 406 of the 2.1 kb transcript parallels that of full-length GATA5 mRNA; both are highly expressed in the sto-407 mach and intestine as well as slightly in lung, liver, and heart ( Figure 1A ). This 3' truncated mRNA 408 should encode the same GATA5 protein as the full-length GATA5 transcript. However, 3' UTR se-409 quences often harbor protein binding sites to stabilize transcript and control polyadenylation and nuclear 410 export (8), and may contain miRNA binding sites that regulate protein translation. We do not yet know 411 the function of the GATA5 3' UTR or whether there is any functional difference between these two tran-412 scripts. However, the finding of this new GATA5 isoform provides a critically important guide to inter-413 preting data concerning GATA5 expression. For example, the GeneChip Mouse Genome 430 2.0 Array 414 (Affymetrix, Santa Clara, CA) is a powerful tool that is widely used for profiling gene expression in 415 mouse tissues; its probe target sequences are selected from current GenBank, dbEST, and RefSeq. Probe 416 set 96500_at (GC content 53%), that targets GATA5 gene sequence from bp +8962-9345, was used to 417 detect GATA5 transcripts in the Affymetrix MG-U74AV2 chip. In the Mouse Genome 430 2.0 Array, 418 probe set 1450125_at (GC content 49.8%) replaced the probe set 96500_at and probe set 1450126_at (GC 419 content 47.3%) was added as a second probe set for GATA5 mRNA. The target sequences for probe 420 1450125_at and 1450126_at are derived from GATA5 cDNA bp 2668-2985 and 1507-2085, respectively. 421 Thus, probe set 1450126_at detects all three isoforms of GATA5 transcripts while the probe set 422 1450125_at only detects full-length GATA5 transcripts and the 2.5 kb GATA5 transcript transcribed from 423 the intron 1 promoter; however, it is insensitive to the 2.1 kb transcript that lacks the 3' terminal 1143 bp 424 of full-length GATA5 exon 6. This suggests that the signal of GATA5 gene detected by probe set 425 1450126_at (which detects all GATA5 mRNAs) should be higher than or at least equal to that detected by 426 probe set 1450125_at (which excludes those that lack the full 3' UTR). Indeed, we confirmed this antic Page 18 ipated result in gene expression data sets from five recent studies (11, 17, 31) , as shown in Table 1 . Thus, 428 comparison of relative signal intensities from these two probe sets may yield insight into the differential 429 abundances of 3'UTR containing or 3'UTR lacking transcripts. 430
431
Our findings also extend current understanding of the tissue distribution of GATA5 expression. Morrisey 432 et al (21) described the temporal and spatial pattern of GATA5 gene expression during mammalian devel-433 opment using in situ hybridization to a GATA5 5' UTR cDNA probe (bp 253-707). Since the 5' UTR 434 cDNA probe cannot detect the alternative 2.5 kb GATA5 mRNA transcribed from the intron 1 promoter, 435 their in situ hybridization results may not have revealed additional tissues that express short, but not full-436 length, GATA5 proteins. In addition, in contrast to the report that GATA5 is not expressed in the heart 437 during late fetal and postnatal development, using the more sensitive RT-PCR method, we discovered that 438 novel and full-length GATA5 transcripts were expressed in adult heart, albeit at low levels. 439
In summary, we have identified an alternative promoter region and two alternative isoforms of GATA5 440 transcripts in mouse. These findings are critical to elucidate the temporal and spatial expression patterns 441 of GATA5 isoforms and their functions. croarrays, as reported in 5 published studies. Signal intensity was almost always greater from probe set 547 1450126_at, which can detect GATA5 transcripts that either contain or lack the distal 3'UTR included in 548 the 3.3 kb but not the 2.1 kb GATA5 transcript. In contrast, probe set 1240125_at detects only those tran-549 scripts that include the distal 3'UTR, and so generally yields a smaller GATA5 hybridization signal. 550 GEO -Gene Expression Omnibus; N -number of paired samples in each publication. 551 full-length GATA5 (B) or pcDNA-GATA5-s, which encodes short GATA5 cDNA (C). Both GATA5 iso-592 forms exhibit nuclear localization. Primary anti-GATA5 antibody used is directed against aa 235-247 of 593 full-length GATA5. GATA5 staining is shown in red and Hoescht nuclear staining is shown in blue, so 594
that nuclear GATA5 appears magenta. F-actin staining (phalloidin) is shown in green. 595 596 Figure 5 . In vitro transactivation experiments indicate that co-transfection with expression plasmid en-597 coding short GATA5 (pcDNA-GATA5-s) transactivates the GATA-sensitive ANF promoter (P<0.0001), 598 though full-length GATA5 (pcDNA-GATA5-f) and GATA4 (pcDNA-GATA4) are more effective. Mean ANF Promoter Activity (Fold Activation)
